ArticleBriefings in bioinformatics2026
VCboost: reducing false positives in long-read variant calling for single-nucleotide polymorphism and indel detection in challenging genomic regions.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Long-read sequencing enables improved genome inference but remains challenged by high error rates that lead to excessive false-positive (FP) variant calls, particularly for small INDELs in complex genomic regions. We present VCboost, a deep learning-based post-calling framework designed to reduce FP in single-nucleotide polymorphism (SNP) and indel detection from long-read sequencing data. VCboost extracts discriminative features from pileup reads and consensus sequences and employs a dedicated filtering model integrating convolutional and recurrent neural networks with residual connections and multi-head attention. Evaluated on multiple human long-read datasets, VCboost consistently improved variant calling performance over Clair3, achieving a 5%-8% increase in precision and a 2%-5% gain in F1-score for INDELs, with minimal recall loss. For SNPs, VCboost improved precision by 4%-8% and F1-score by 2%-5%, with negligible impact on recall. Substantial performance gains were observed in difficult-to-map regions, including low-mappability and segmental-duplication regions, where SNP precision increased by up to 17.6%. Overall, VCboost effectively enhances the accuracy of long-read variant calling while preserving high sensitivity, offering a robust solution for variant detection in challenging genomic regions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.